Hikma Pharmaceuticals PLC
HIK
Rank in Stocks
#3510
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Share Price
$21.90
Last synced: 2026-11-12
Market Cap
$4.64B
Change (1 day)
-0.18%
Change (1 year)
4.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Hikma Pharmaceuticals PLC (HIK)
Category
Healthcare
Operating Margin for Hikma Pharmaceuticals PLC (HIK)
Operating Margin as of November 2026 TTM: 19.41%
According to Hikma Pharmaceuticals PLC's latest financial reports, its current operating margin (TTM) is 19.41%. At the end of 2025 the company had an operating margin of 17.32%.
Operating Margin history for Hikma Pharmaceuticals PLC from 2002 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 19.41% | 12.07% |
| 2025 | 17.32% | -11.50% |
| 2024 | 19.57% | 53.25% |
| 2023 | 12.77% | -45.61% |
| 2022 | 23.48% | -5.44% |
| 2021 | 24.83% | 7.63% |
| 2020 | 23.07% | 4.77% |
| 2019 | 22.02% | 6.48% |
| 2018 | 20.68% | 19.12% |
| 2017 | 17.36% | -15.56% |
| 2016 | 20.56% | -24.66% |
| 2015 | 27.29% | -3.02% |
| 2014 | 28.14% | -2.76% |
| 2013 | 28.94% | 92.16% |
| 2012 | 15.06% | 16.47% |
| 2011 | 12.93% | -30.03% |
| 2010 | 18.48% | 9.67% |
| 2009 | 16.85% | 21.31% |
| 2008 | 13.89% | -32.54% |
| 2007 | 20.59% | -13.27% |
| 2006 | 23.74% | -10.04% |
| 2005 | 26.39% | -10.63% |
| 2004 | 29.53% | 0.20% |
| 2003 | 29.47% | 12.18% |
| 2002 | 26.27% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -99.00% |
DE
|
|
| 19.68% | -98.99% |
DE
|
|
| 13.26% | -99.32% |
JP
|
|
| 17.08% | -99.12% |
CH
|
|
| 14.92% | -99.23% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Hikma Pharmaceuticals PLC's operating margin
What is Hikma Pharmaceuticals PLC's operating margin?
Hikma Pharmaceuticals PLC's operating margin is 19.41%, as of Nov 2026.
What was Hikma Pharmaceuticals PLC's operating margin in 2025?
In 2025, Hikma Pharmaceuticals PLC's operating margin was 17.32%, compared with 19.57% in 2024.
How has Hikma Pharmaceuticals PLC's operating margin changed since 2020?
From 2020 to 2025, Hikma Pharmaceuticals PLC's operating margin was highest in 2021 (24.83%) and lowest in 2023 (12.77%).
How does Hikma Pharmaceuticals PLC's operating margin compare with similar companies?
Hikma Pharmaceuticals PLC's operating margin (19.41%) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.